2017 Q2 Form 10-K Financial Statement

#000114420417026149 Filed on May 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q2
Revenue $0.00
YoY Change
Cost Of Revenue $192.0K
YoY Change
Gross Profit -$192.0K
YoY Change
Gross Profit Margin
Selling, General & Admin $1.390M
YoY Change -2085.71%
% of Gross Profit
Research & Development $9.297K
YoY Change
% of Gross Profit
Depreciation & Amortization $60.00K
YoY Change
% of Gross Profit
Operating Expenses $9.297K
YoY Change -113.28%
Operating Profit -$1.592M
YoY Change 3028.67%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.436K
YoY Change -54.27%
Pretax Income -$1.590M
YoY Change -2371.43%
Income Tax
% Of Pretax Income
Net Earnings -$1.588M
YoY Change -2369.1%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$2.65
COMMON SHARES
Basic Shares Outstanding 25.98M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.400M
YoY Change -39.13%
Cash & Equivalents $1.448M
Short-Term Investments
Other Short-Term Assets $100.0K
YoY Change 681.43%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.545M
YoY Change -31.84%
LONG-TERM ASSETS
Property, Plant & Equipment $1.885M
YoY Change
Goodwill
YoY Change
Intangibles $20.00K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.955M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.545M
Total Long-Term Assets $1.955M
Total Assets $3.500M
YoY Change 54.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00
YoY Change -100.0%
Accrued Expenses $122.6K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $293.9K
YoY Change 243.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $293.9K
Total Long-Term Liabilities $0.00
Total Liabilities $300.0K
YoY Change 200.0%
SHAREHOLDERS EQUITY
Retained Earnings -$4.781M
YoY Change -92.37%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.988M
YoY Change
Total Liabilities & Shareholders Equity $3.450M
YoY Change 52.2%

Cashflow Statement

Concept 2017 Q2
OPERATING ACTIVITIES
Net Income -$1.588M
YoY Change -2369.1%
Depreciation, Depletion And Amortization $60.00K
YoY Change
Cash From Operating Activities -$1.200M
YoY Change 2300.0%
INVESTING ACTIVITIES
Capital Expenditures $520.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$520.0K
YoY Change -326.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 60.00K
YoY Change
NET CHANGE
Cash From Operating Activities -1.200M
Cash From Investing Activities -520.0K
Cash From Financing Activities 60.00K
Net Change In Cash -1.660M
YoY Change -1022.22%
FREE CASH FLOW
Cash From Operating Activities -$1.200M
Capital Expenditures $520.0K
Free Cash Flow -$1.720M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
theMaven, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0000894871
dei Trading Symbol
TradingSymbol
MVEN
CY2016Q4 us-gaap Cash
Cash
598294 USD
CY2016Q4 us-gaap Assets
Assets
1287685 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
154361 USD
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
137177 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
346327 USD
CY2016Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
168496 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
220475 USD
CY2016Q4 mven Common Stock Value To Be Issued
CommonStockValueToBeIssued
9375 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2730770 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2187758 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
772862 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1287685 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1772169 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2183910 USD
us-gaap Investment Income Net
InvestmentIncomeNet
11173 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1385 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-16406 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3848 USD
us-gaap Net Income Loss
NetIncomeLoss
-2187758 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
16406 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
16406 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2187758 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1105769 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
116171 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1137913 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
518532 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
598294 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
598294 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
947351 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2187758 USD
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
137177 USD
dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q2 dei Entity Public Float
EntityPublicFloat
887147 USD
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25983461 shares
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
121587 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
547804 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
54789 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> </div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1. Nature of Operations</font></b></div> <div style="CLEAR:both;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; TEXT-AUTOSPACE: ; FONT-SIZE: 11pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">theMaven, Inc. (&#8220;Parent&#8221;) and theMaven Network, Inc. (&#8220;Subsidiary&#8221;) (collectively &#8220;theMaven&#8221; or the &#8220;Company&#8221;) are developing an exclusive network of professionally managed online media channels, with an underlying technology platform. Each channel will be operated by a &#8220;invite only&#8221; &#8220;Channel Partner&#8221; drawn from subject matter experts, reporters, group evangelists and social leaders. Channel Partners will publish content and oversee an online community for their respective channels, leveraging a proprietary, socially-driven, mobile-enabled, video-focused technology platform to engage niche audiences within a single network.</font>&#160;</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2. Basis of Presentation</font></b></div> <div style="CLEAR:both;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; TEXT-AUTOSPACE: ; FONT-SIZE: 11pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">theMaven Network, Inc. was incorporated in Nevada on July 22, 2016, under the name &#8220;Amplify Media, Inc.&#8221; On July 27, 2016, the corporate name was amended to &#8220;Amplify Media Network, Inc.&#8221; and on October 14, 2016, the corporate name was changed to &#8220;theMaven Network, Inc.&#8221;.</font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; TEXT-AUTOSPACE: ; FONT-SIZE: 11pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; TEXT-AUTOSPACE: ; FONT-SIZE: 11pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt"> theMaven, Inc. was formerly known as Integrated Surgical Systems, Inc., a Delaware corporation (&#8220;<i>Integrated</i>&#8221;).&#160; From June 2007 until November 4, 2016, Integrated was a non-active &#8220;shell company&#8221; as defined by regulations of the Securities and Exchange Commission (SEC). On August 11, 2016, Integrated entered into a loan to Subsidiary that provided initial funding totalling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">735,099</font> for the Subsidiary&#8217;s operations. On October 14, 2016 Integrated entered into a Share Exchange Agreement (the &#8220;<i>Share Exchange Agreement</i>&#8221;) with Subsidiary and the shareholders of Subsidiary, holding all of the issued and outstanding shares of Subsidiary (collectively, &#8220;<i>Subsidiary Shareholders</i>&#8221;). The Share Exchange Agreement was amended on November 4, 2016 to include certain newly issued shares of Subsidiary in the transaction and make related changes to the agreement and the Share Exchange was consummated. The transaction resulted in Parent acquiring Subsidiary by the exchange of all of the outstanding shares of Subsidiary for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 12,517,152</font> newly issued shares of the common stock, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.01</font> par value (the &#8220;<i>Common Stock</i>&#8221;) of Parent, representing approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 56.7</font>% of the issued and outstanding shares of Common Stock immediately after the transaction. The transaction is referred to as the &#8220;Recapitalization.&#8221; The Recapitalization was consummated on November 4, 2016, as a result of which theMaven Network, Inc. became a wholly owned subsidiary of Integrated (the &#8220;<i>Closing</i>&#8221;).</font> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt"> The note payable between Integrated and Subsidiary was an interdependent transaction with the Recapitalization and was ultimately cancelled upon closing of the Recapitalization. On December 2, 2016, Integrated amended its Certificate of Incorporation to change its name from &#8220;Integrated Surgical Systems, Inc.&#8221; to &#8220;theMaven, Inc.&#8221;</font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; TEXT-AUTOSPACE: ; FONT-SIZE: 11pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; TEXT-AUTOSPACE: ; FONT-SIZE: 11pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt"> From June 2007 until the closing of the Recapitalization, Integrated was a non-active &#8220;shell company&#8221; as defined by regulations of the SEC and, accordingly, the Recapitalization was accounted for as a reverse recapitalization rather than a business combination. As the Subsidiary is deemed to be the purchaser for accounting purposes under reverse recapitalization accounting, the Company&#8217;s financial statements are presented as a continuation of Subsidiary, and the accounting for the Recapitalization is</font> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt"> equivalent to the issuance of stock by Subsidiary for the net monetary assets of Parent as of the Closing accompanied by a recapitalization. &#160;See Note 9 for summary of the assets acquired, transaction costs and the consideration exchanged in the Recapitalization.</font>&#160;</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22047531 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22047531 shares
us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
411741 USD
us-gaap Operating Expenses
OperatingExpenses
2183910 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3353282 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" align="justify"></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" align="justify"><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of Estimates</font></i></div> <div style="CLEAR:both;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; TEXT-AUTOSPACE: ; FONT-SIZE: 11pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.&#160;&#160;Actual results could materially differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; TEXT-AUTOSPACE: ; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Concentrations of Credit Risk</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2952 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2016Q4 mven Interest Rate Per Month Percentage
InterestRatePerMonthPercentage
0.18 pure
us-gaap Depreciation
Depreciation
390 USD
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
977426 USD
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
735099 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14510126 shares
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1238893 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6250 USD
CY2016Q4 mven Franchise Tax Payable
FranchiseTaxPayable
44000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
117830 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-69676 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
408819 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
548194 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
390 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2952 USD
mven Cash Acquired Upon Reverse Recapitalization
CashAcquiredUponReverseRecapitalization
479624 USD
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
735099 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1217675 USD
CY2016Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
744105 USD
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
735000 USD
mven Class Of Warrant Or Rightterm
ClassOfWarrantOrRightterm
P5Y
CY2016Q4 mven Class Of Warrant Or Rightholding Percentage
ClassOfWarrantOrRightholdingPercentage
0.05 pure
CY2016Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1169607 shares
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.20
CY2016Q4 mven Deferred Tax Assets Accrued Liabilities Not Currently Deductible
DeferredTaxAssetsAccruedLiabilitiesNotCurrentlyDeductible
64210 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
506259 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
570469 USD
CY2016Q4 mven Deferred Tax Liabilities Deferred Expense Share Based Compensation
DeferredTaxLiabilitiesDeferredExpenseShareBasedCompensation
16625 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
136263 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
417581 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
152888 USD
CY2016Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
138562 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-1385 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-743838 USD
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
373367 USD
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
370470 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.171 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.169 pure
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
35000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
35000 USD
CY2016Q4 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
735099 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
175000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100137 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1570730 shares
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1670867 shares
mven Reclssification Of Sharebased Compensation To Website Development Costs
ReclssificationOfSharebasedCompensationToWebsiteDevelopmentCosts
139375 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.88
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23392138 shares
CY2016Q4 us-gaap Equity Fair Value Disclosure
EquityFairValueDisclosure
4403464 USD
CY2016Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1.0 pure
CY2016Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
2952 USD
CY2016Q3 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.0002
CY2016Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
7966070 shares
CY2016Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
4094708 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
beginning August 1, 2016 with one-third vesting on August 1, 2017 and the balance monthly over the remaining two years
CY2016Q4 mven Recapitalization Number Of Shares Transfer To Escrow Account
RecapitalizationNumberOfSharesTransferToEscrowAccount
4094708 shares
CY2016Q4 mven Number Of Shares In Escrow Subject To Performance Condition
NumberOfSharesInEscrowSubjectToPerformanceCondition
4381003 shares
CY2016Q4 mven Common Stock Share Percentage Escrowed
CommonStockSharePercentageEscrowed
0.35 pure
CY2016Q4 mven Percentage Of Escrow Shares To Be Released Subject To Performance Condition
PercentageOfEscrowSharesToBeReleasedSubjectToPerformanceCondition
0.725 pure
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
82816 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D

Files In Submission

Name View Source Status
0001144204-17-026149-index-headers.html Edgar Link pending
0001144204-17-026149-index.html Edgar Link pending
0001144204-17-026149.txt Edgar Link pending
0001144204-17-026149-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mven-20161231.xml Edgar Link completed
mven-20161231.xsd Edgar Link pending
mven-20161231_cal.xml Edgar Link unprocessable
mven-20161231_def.xml Edgar Link unprocessable
mven-20161231_lab.xml Edgar Link unprocessable
mven-20161231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v463892_10k.htm Edgar Link pending
v463892_ex21-1.htm Edgar Link pending
v463892_ex31-1.htm Edgar Link pending
v463892_ex31-2.htm Edgar Link pending
v463892_ex32-1.htm Edgar Link pending
v463892_ex32-2.htm Edgar Link pending
v463892_ex4-3.htm Edgar Link pending
v463892_ex4-4.htm Edgar Link pending